← Evidence map

ArticleHIV/AIDS (Auckland, N.Z.)2013

Potential benefit of dolutegravir once daily: efficacy and safety.

Alessandra Fantauzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23413040